Quick Answer
INTELLIGENT BIO SOLUTIONS INC. reported Stockholders Equity of $3.00 million for the year ending 2025.
- INTELLIGENT BIO SOLUTIONS INC. showed a decrease of -64.0% in Stockholders Equity from 2024 to 2025.
- This data is from INTELLIGENT BIO SOLUTIONS INC.'s annual report (Form 10-K), filed with the SEC on August 15, 2025.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2020: $18.82 million | Q1 2021: $15.93 million | Q3 2021: $13.56 million | Q4 2021: $10.11 million | Q1 2022: $8.77 million | Q3 2022: $5.28 million | Q4 2022: $10.35 million | Q1 2023: $6.03 million | Q3 2023: $1.36 million | Q4 2023: $3.28 million | Q1 2024: $11.13 million | Q3 2024: $6.10 million | Q4 2024: $4.37 million | Q1 2025: $5.11 million | Q2 2025: $3.00 million | Q3 2025: $3.62 million | Q4 2025: $11.09 million.
- Over the full 7 years of available data (2019 to 2025), INTELLIGENT BIO SOLUTIONS INC.'s Stockholders Equity has grown by 175.3%.
- Historical annual values: Fiscal year 2025: $3.00 million | Fiscal year 2024: $8.33 million | Fiscal year 2023: $3.80 million | Fiscal year 2022: $6.62 million | Fiscal year 2021: $15.06 million | Fiscal year 2020: -$5.19 million | Fiscal year 2019: -$3.98 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: